Artículos por temáticas

Cerebellar ataxia, vertical supranuclear gaze palsy, sensorineural deafness, epilepsy, dementia, and hallucinations in an adolescent male.

Tsao CY.

Semin Pediatr Neurol. 2014 Jun;21(2):106-8. doi: 10.1016/j.spen.2014.04.012.

Celiac disease and malabsorption: a case report of ataxia secondary to vitamin E deficiency.

Suárez Llanos JP, González Melo E, Mora Mendoza A, Iacampo Leiva LD, Moro Miguel MA.

Endocrinol Nutr. 2014 Aug-Sep;61(7):389-90. doi: 10.1016/j.endonu.2014.03.013. English, Spanish. No abstract available.

Genetics of Parkinson's disease and other diseases of the extrapyramidal system.

Dorszewska J.

Curr Genomics. 2014 Feb;15(1):1. doi: 10.2174/138920291501140306110937. No abstract available.

Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease.

Arawaka S, Fukushima S, Sato H, Sasaki A, Koga K, Koyama S, Kato T.

PLoS One. 2014 Feb 20;9(2):e89076. doi: 10.1371/journal.pone.0089076.

High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington's disease.

Hu Y, Liang J, Yu S.

J Alzheimers Dis. 2014;40(4):863-8. doi: 10.3233/JAD-131847.

Technical and clinical view on ambulatory assessment in Parkinson's disease.

Hobert MA, Maetzler W, Aminian K, Chiari L.

Acta Neurol Scand. 2014 Sep;130(3):139-47. doi: 10.1111/ane.12248. Review.

Cell Therapy Strategies vs. Paracrine Effect in Huntington's Disease.

Im W, Kim M.

J Mov Disord. 2014 Apr;7(1):1-6. doi: 10.14802/jmd.14001. Review.

A closer look at mechanisms underlying perceptual differences in Parkinson's freezers and non-freezers.

Ehgoetz Martens KA, Ellard CG, Almeida QJ.

Neuroscience. 2014 Aug 22;274:162-9. doi: 10.1016/j.neuroscience.2014.05.022.

Parkinson's disease and carotid intima-media thickness.

Alexa D, Constantinescu A, Baltag D, Ignat B, Bolbocean O, Popescu CD.

Rev Med Chir Soc Med Nat Iasi. 2014 Jan-Mar;118(1):52-6.

Animal models of Huntington's disease for translation to the clinic: best practices.

Menalled L, Brunner D.

Mov Disord. 2014 Sep 15;29(11):1375-90. doi: 10.1002/mds.26006. Review.

Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.

Egevad G, Petkova VY, Vilholm OJ.

J Parkinsons Dis. 2014;4(3):321-6. doi: 10.3233/JPD-140379.

[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.

Brigo F, Matinella A, Erro R, Tinazzi M.

Eur J Neurol. 2014 Nov;21(11):1369-e90. doi: 10.1111/ene.12444.

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D.

Neurology. 2014 Aug 26;83(9):826-33. doi: 10.1212/WNL.0000000000000729.

Observations on sleep-disordered breathing in idiopathic Parkinson's disease.

Valko PO, Hauser S, Sommerauer M, Werth E, Baumann CR.

PLoS One. 2014 Jun 26;9(6):e100828. doi: 10.1371/journal.pone.0100828.

Functional imaging in pre-motor Parkinson's disease.

Arnaldi D, Morbelli S, Picco A, Ferrara M, Buschiazzo A, Famà F, De Carli F, Nobili F.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):366-75. Review.